407 related articles for article (PubMed ID: 27304613)
1. Paraneoplastic epilepsy.
Serafini A; Lukas RV; VanHaerents S; Warnke P; Tao JX; Rose S; Wu S
Epilepsy Behav; 2016 Aug; 61():51-58. PubMed ID: 27304613
[TBL] [Abstract][Full Text] [Related]
2. Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.
Grativvol RS; Cavalcante WCP; Castro LHM; Nitrini R; Simabukuro MM
Curr Oncol Rep; 2018 Nov; 20(11):92. PubMed ID: 30415318
[TBL] [Abstract][Full Text] [Related]
3. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
4. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
5. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
[TBL] [Abstract][Full Text] [Related]
6. Rasmussen Syndrome and Other Inflammatory Epilepsies.
Varadkar S; Cross JH
Semin Neurol; 2015 Jun; 35(3):259-68. PubMed ID: 26060905
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune Epilepsy.
Gaspard N
Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):227-45. PubMed ID: 26844739
[TBL] [Abstract][Full Text] [Related]
8. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.
Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A
Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997
[TBL] [Abstract][Full Text] [Related]
9. Role of antineuronal antibodies in children with encephalopathy and febrile status epilepticus.
Lin KL; Wang HS
Pediatr Neonatol; 2014 Jun; 55(3):161-7. PubMed ID: 24050844
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic Disorders.
Lancaster E
Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1653-1679. PubMed ID: 29200116
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune epilepsy in children: case series and proposed guidelines for identification.
Suleiman J; Brilot F; Lang B; Vincent A; Dale RC
Epilepsia; 2013 Jun; 54(6):1036-45. PubMed ID: 23551014
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
Bastiaansen AEM; van Sonderen A; Titulaer MJ
Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
[TBL] [Abstract][Full Text] [Related]
13. Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2.
Michael S; Waters P; Irani SR
Pract Neurol; 2020 Oct; 20(5):377-384. PubMed ID: 32595134
[TBL] [Abstract][Full Text] [Related]
14. Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex.
Montojo MT; Petit-Pedrol M; Graus F; Dalmau J
Neurologia; 2015 Jun; 30(5):295-301. PubMed ID: 24485651
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis.
Rosenfeld MR; Dalmau JO
Continuum (Minneap Minn); 2012 Apr; 18(2):366-83. PubMed ID: 22810133
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies and epilepsy.
Bien CG; Scheffer IE
Epilepsia; 2011 May; 52 Suppl 3():18-22. PubMed ID: 21542841
[TBL] [Abstract][Full Text] [Related]
17. [Recent changes in the paradigm of limbic encephalitis].
Illés Z
Ideggyogy Sz; 2011 Jul; 64(7-8):222-8. PubMed ID: 21863688
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune epilepsy.
Britton J
Handb Clin Neurol; 2016; 133():219-45. PubMed ID: 27112680
[TBL] [Abstract][Full Text] [Related]
19. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
[TBL] [Abstract][Full Text] [Related]
20. [Paraneoplastic neurological syndromes : A current summary].
De Simoni D; Höftberger R
Internist (Berl); 2018 Feb; 59(2):151-158. PubMed ID: 29327271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
